Publications by authors named "Annalisa Pezzolo"

47Publications

Ezrin interacts with the tumor suppressor CHL1 and promotes neuronal differentiation of human neuroblastoma.

PLoS One 2020 16;15(12):e0244069. Epub 2020 Dec 16.

Laboratorio Cellule Staminali Post Natali e Terapie Cellulari, IRCCS Istituto Giannina Gaslini, Genova, Italy.

View Article and Find Full Text PDF
December 2020

Roniciclib down-regulates stemness and inhibits cell growth by inducing nucleolar stress in neuroblastoma.

Sci Rep 2020 07 31;10(1):12902. Epub 2020 Jul 31.

Laboratorio Cellule Staminali Post Natali e Terapie Cellulari, IRCCS Istituto Gaslini, 16147, Genova, Italy.

View Article and Find Full Text PDF
July 2020

The Over-Expression of E2F3 Might Serve as Prognostic Marker for Neuroblastoma Patients with Stage 4S Disease.

Diagnostics (Basel) 2020 05 16;10(5). Epub 2020 May 16.

U.O.C. Laboratorio Cellule Staminali Post Natali e Terapie Cellulari, IRCCS Istituto Giannina Gaslini, 16147 Genova, Italy.

View Article and Find Full Text PDF
May 2020

19p loss is significantly enriched in older age neuroblastoma patients and correlates with poor prognosis.

NPJ Genom Med 2020 15;5:18. Epub 2020 Apr 15.

1Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Napoli, Italy.

View Article and Find Full Text PDF
April 2020

Identification of a minimal region of loss on chromosome 6q27 associated with poor survival of high-risk neuroblastoma patients.

Cancer Biol Ther 2020 05 20;21(5):391-399. Epub 2020 Jan 20.

Laboratorio Cellule Staminali Post Natali e Terapie Cellulari, IRCCS Istituto Gaslini, Genova, Italy.

View Article and Find Full Text PDF
May 2020

Role of GOLPH3 and TPX2 in Neuroblastoma DNA Damage Response and Cell Resistance to Chemotherapy.

Int J Mol Sci 2019 Sep 25;20(19). Epub 2019 Sep 25.

Laboratorio Cellule Staminali Post Natali e Terapie Cellulari, IRCCS Giannina Gaslini, 16147 Genova, Italy.

View Article and Find Full Text PDF
September 2019

Neuroblastoma Cell Lines Are Refractory to Genotoxic Drug-Mediated Induction of Ligands for NK Cell-Activating Receptors.

J Immunol Res 2018 1;2018:4972410. Epub 2018 Apr 1.

Department of Pediatric Hematology and Oncology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

View Article and Find Full Text PDF
September 2018

Involvement of HMGB1 in Resistance to Tumor Vessel-Targeted, Monoclonal Antibody-Based Immunotherapy.

J Immunol Res 2016 27;2016:3142365. Epub 2016 Jan 27.

Laboratorio di Oncologia, Istituto Giannina Gaslini, 16147 Genova, Italy.

View Article and Find Full Text PDF
November 2016